 previous article in this issue | next article in this issue  |
|
Document Details : Title: Regression of Left Ventricular Hypertrophy During Antihypertensive Treatment Author(s): FOADING DEFFO, Bertin Journal: Acta Cardiologica Volume: 61 Issue: 4 Date: August 2006 Pages: 485-488 DOI: 10.2143/AC.61.4.2017313 Abstract : Left ventricular hypertrophy is a risk factor for cardiovascular events and stroke. It has been demonstrated that the regression of left ventricular hypertrophy (evaluated by 12-lead electrocardiography and by echocardiography) during antihypertensive treatment is associated with a lower risk of cardiovascular mortality and may thus improve the prognosis. Black people run a disproportionately high risk of developing essential arterial hypertension which frequently results in end organ damage, including left ventricular hypertrophy, haemorrhagic stroke and renal failure. We report a case of significant regression of left ventricular hypertrophy in a sub-Saharan African patient, during antihypertensive treatment. |
